Nkarta gives first look at two 'natural killer' cell therapies for blood cancer
Bio Pharma Dive
APRIL 25, 2022
The results build on early evidence that NK cell treatments may become viable medicines for leukemia and lymphoma, while it's still unclear whether they're as effective, or last as long, as T cell therapies.
Let's personalize your content